Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
TRex Bio Inc.

TRex Bio Inc. (TRXB) Stock Overview

Explore TRex Bio Inc.’s financial performance, market position, analyst ratings, and future outlook.

TRXB●NASDAQ
HealthcareMedical - Pharmaceuticals
$13.60
$0.43(3.06%)
U.S. Market opens in 15h 6m

TRex Bio Inc. (TRXB)

Meyka AI Score

Z

Key Financials

Market Cap113.3M
P/E RatioN/A
EPS (TTM)$-2.47
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

TRXB Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of TRex Bio Inc. (NASDAQ: TRXB) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, TRex Bio Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TRXB on the NASDAQ shows an RSI of 6.67, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind TRex Bio Inc.'s NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 113.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of TRXB on the NASDAQ.

Price Performance (NASDAQ: TRXB)

1-Day Change
-3.06%
5-Day Change
0.74%
1-Month Change
0.001%
3-Month Change
0.001%
6-Month Change
0.001%
Year-to-Date (YTD) Change
0.001%
1-Year Change
0.001%
3-Year Change
0.001%
5-Year Change
0.001%
All-Time (Max) Change
0.001%

Contact Information

http://www.trex.bio
NaN
269 E. Grand Ave., Suite 300, South San Francisco, CA, 94080

Company Facts

IPO DateOct 9, 2026
CountryUS
Actively Trading

Frequently Asked Questions